Curriculum Vitae for Faculty Members
Name
ISMET AYDOGDU
Title
M.D./PROF. DR
Department
DEPARTMENT OF INTERNAL MEDICINE, DIVISION OF HEMATOLOGY
Date of Birth
01.11.1957
Place of Birth
BORLU/MANISA
Area(s) of
interest
HEMATOLOGY, STEM CELL TRANSPLANTATION, MORPHOLOGY OF HEMATOLOGY,
LEUKEMIAS, LYMPHOMAS, MALIGNANT HEMATOLOGY
Correspondence
Phone
+90 236 2360330/3564
E-mail
sacayak@gmail.com
GSM
+90 532 5854385
1
Education
Undergraduate
Manisa High School
1975
Masters degree
Ankara University Medical Faculty
1982
Specialty/Doctorate
Ankara Hospital, Internal Medicine
1986-1990
Subspecialty
Ankara University Medical Faculty Dept. of Hematology
1991-1993
Academic Titles
Assistant Professor
Inonu University Medical Faculty
Internal medicine/Hematology
Associate Professor
Inonu University Medical Faculty
Internal medicine/Hematology
Professor
Inonu University Medical Faculty
Internal medicine/Hematology
1994-1997
1998-2003
2003-
Administrative
Duties
Memberships and T
Affiliations
Turkısh Hematology Association
Turkish Medical Association
SELECTED PUBLICATIONS
1. H. Akan, M. Beksaç, I. Aydogdu, H. Koç, O. İlhan, M. Özcan. Peripheral T cell receptors  and  in patients
with hodgkin’s lymphoma. British Journal of Haematology 87: 544-547, 1994
2. O. İlhan, H. Koç, I. Aydogdu, M. Beksaç, H. Akan, N. Konuk, A. Uysal. Combined immuno suppressive therapy
in aplastic anaemia. Indian Journal of Medical Research 102: 143-146, 1995
3. H. Koç, Ö. Arslan, G. Gürman, H. Akan, M. Özcan, O. İlhan, I. Aydogdu, M. Arat, M. Beksaç, N. Konuk, A.
Uysal. The use of high dose chemotherapy plus granulocyte- colony stimulating factor for the salvage of
refractory resistant relapse malignant lymphoma patients without stem cell support. Acta Haematologica 98:
136-139
4. H. Akan, N. Güven, I. Aydogdu, M. Arat, M. Beksaç, K. Dalva. Trombopoietic cytokines in patients with iron
deficiency anemia with or without thrombocytosis. Acta Haematologica 103: 152-156, 2000
5. Giles FJ, Shan J, SH. Advani, I. H. Akan, I. Aydogdu, Z. Aziz, H. Azim, P. P. Bapsy, F. Büyükkeçeci, B.
Chaimongkol, P. Chen, S. Cheong, B. Ferhanoğlu, R. Hamza, H. M. Khalid, T. İntragumtornchai, S. W. Kim, S. Y.
Kim, H. Koç, L. Kumar, R. Kumar, K. İ. Lei, A. Lekhakula, A. Muthalib, M. Patel, V. P. Poovalingam, W.
Prayoonwiwat, F. Rana, A. H. Reksodiputro, P. Ruff, T. G. Sagar, A. P. Schwarer, H. S. Song, C. W. Suh, C. Suharti,
İ. Supindiman, G. Y. Tee, T. Thramprasit, A. H. Villalon, N. R. Wickham, J. E. Wong, A. Yalçın, S. Jootar. A
prospective randomized study of Chop plus alpha-2b interferon in patients with intermediate and high grade
Non-Hodgkin’s lymphoma: the international oncology study group NHL1 study. Leuk Lymphoma 40: 95-103,
2000
6. I.Aydoğdu, R. Sarı, R. Ulu, A. Sevinç. The frequency of gallbladder stones in patients with pernicious anemia.
Journal of Surgical Research 101: 120-123, 2001
2
7. Yildirim Z, Turkoz Y, Kotuk M, Armutcu F, Gurel A, Iraz M, Ozen S, Aydogdu I, Akyol O. Effects of
aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats. Nitric Oxide 11: 156165, 2004
8. Ismet A, Irfan K, Emin K, Ali EM, Ramazan U, Mustafa B, Onur O. Splenectomy Results in Patients with
Idiopathic Thrombocytopenic Purpura: 10 Years of
Experience in Turgut Ozal Medical Center. Clin.Lab.Haem. 2004;26:211-214
9. I Kuku, MR Bayraktar, E Kaya, MA Erkurt, N Bayraktar, K Cıkım, I Aydogdu. Serum proinflammatory mediators
at different periods of therapy in patients with multiple myeloma. Mediators of Inflammation 2005: 171-174,
2005
10. K. Serefhanoglu, Y. Ersoy, S. Serefhanoglu, I. Aydogdu, I. Kuku, E. Kaya. Clinical experience with three
combination regimens for the treatment of high-risk febrile neutropenia. Ann Acad Med Singapore 35: 11-16,
2006
11. Altuntas F, Aydogdu I, Kabukcu S, Kocyigit I, Cikim K, Sari I, Erkut MA, Eser B, Ozturk A, Kaya E, Cetin M,
Keskin A, Unal A. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a
retrospective multicenter study. Transfus Apher Sci. 36: 57-67, 2007
12. Erkurt MA, Aydogdu I, Kuku I, Kaya E, Basaran Y. Clinicopathologic Characteristics and Therapeutic
Outcomes of Primary Gastrointestinal Non-Hodgkin's Lymphomas: 10 Years of Experience from a Single Centre
in Eastern Anatolia. Med Princ Pract 2009;18:399-406
13. Beksac M, Haznedar R, Firatli-Tuglular T, Ozdogu H, Aydogdu I, Konuk N, Sucak G, Kaygusuz I, Karakus S,
Kaya E, Ali R, Gulbas Z, Ozet G, Goker H, Undar L. Addition of thalidomide to oral melphalan/prednisone in
patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish
Myeloma Study Group. Eur J Haematol. 2011 Jan;86(1):16-22
14. Kayrak M, Acar K, Gul EE, Bağlıcaklıoğlu M, Kaya Z, Sonmez O, Aydogdu I.
Assessment of left ventricular myocardial performance by tissue Doppler echocardiography in patients with
polycythemia vera. Echocardiography. 2011 Oct;28(9):948-54
15. Mehmet Ali Erkurt, Ismet Aydogdu, Irfan Kuku, Emin Kaya, Melda Comert, Yalcin Basaran. Natriuretic
Peptides’ Role in Determining the Chemotherapy-Induced Nephrotoxicity and Their Value in Follow-Up. World J
Nephrol Urol, 2012;1(1):16-22,
3